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ABSTRACT The human CCNDI cyclin Dl/PRADI gene
was previously identified by a genetic screen for G1 cyclin
function in Saccharomyces cerevisiae and also was identified as
the putative BCLI oncogene. However, its role in human cell
proliferation is not known. To determine if expression of
human D-type cyclin genes correlates with the state of cell
growth, we examined the level of mRNAs for CCNDI and a
related gene, CCND3, in normal human diploid fibroblasts
(HDF). The levels of both mRNAs decrease upon serum
depletion or at high cell densities. Following stimulation of
quiescent fibroblasts with serum, the mRNA levels increase
gradually to a peak at about 12 hr, prior to the onset ofS phase.
Induction of cyclin gene expression by serum is reduced
concomitantly with the decline in FOS induction in aging
HDFs, suggesting a possible relationship to the decrease in the
proliferative response to mitogens during cellular senescence.
Cycloheximide partially blocks the induction of CCNDI and
CCND3 gene expression by serum, suggesting that both de novo
protein synthesis-dependent and -independent pathways con-
tribute to induction. Treatment of HDFs with defied growth
factors suggests a correlation between CCND mRNA induction
and DNA synthesis. However, induction of these genes is not
sufficient for the transition from quiescence through GI into S
phase.
The proliferation of eukaryotic cells is controlled at specific
points in the cell cycle, particularly at the G1 to S and the G2
to M transitions. Through a combined biochemical and
genetic approach, protein complexes with protein kinase
activity have been identified as key components that regulate
these transitions. In the G2 to M transition, the cdc2/CDC28
protein is the catalytic subunit of the kinase, and its binding
to mitotic cyclins is a prerequisite for kinase activation (1).
Similar control mechanisms seem to be involved in the G1 to
S transition. In budding yeast, the accumulation of the G1
cyclins CLN1, CLN2, and CLN3 is rate limiting for CDC28
protein kinase activity and passage through a point in G1
termed START, and deletion of all the yeast CLN genes
causes a lethal G1 arrest (2). Mammalian cells have an
analogous commitment point for entry into S phase, which
has been termed the "restriction point" (3). The high con-
servation of the cell-cycle-control machinery in eukaryotic
cells suggests that, like yeast, mammalian cells possess G,
cyclins.
In an effort to identify mammalian G1 cyclins, human
cDNA libraries were screened for cDNAs with the ability to
rescue a Saccharomyces cerevisiae mutant lacking functional
CLN genes (4-6). One of the isolated clones encoded a cyclin
termed cyclin D1 that was distinct in structure from previ-
ously described cyclins (4). The gene encoding cyclin D1,
CCNDJ, is the human homolog of a mouse Ccnl gene called
"CYLl" for cyclin-like (7), which was isolated as a cDNA
clone from mouse macrophages stimulated by colony-
stimulating factor 1 (CSF-1). The gene encoding human
cyclin D1 was also identified as PRADI, a gene rearranged in
parathyroid tumors (8). PRADI is closely linked to BCLI (9),
a locus activated by rearrangement in some B-cell tumors
where PRADI is also overexpressed, suggesting that PRADI
may be the BCLI oncogene. The finding that deregulated
expression of this cyclin gene may contribute to tumorige-
nicity suggests that cyclin D1/PRADI could be involved in
the control of cell proliferation.
Subsequently, two additional genes, CCND2 and CCND3,
encoding human D-type cyclins D2 and D3 were isolated by
low-stringency hybridization and PCR techniques (10, 11).
These genes share high sequence similarity with their murine
counterparts (called "CYL2" and "CYL3" in refs. 7 and 12).
All three human D-type cyclin genes encode small [33-34
kilodalton (kDa)] proteins that share an average of 57%
identity over the entire coding region and 78% in the cyclin
box. In this study, we asked how the expression of human
D-type cyclin genes relates to the state of cell growth. As
suggested by the expression of mitotic cyclins, which peak at
the G2 toM transition, ifD-type cyclins are indeed G1 cyclins,
their expression might peak in late G1 and be rate-limiting for
the G1 to S transition. Therefore, we examined the level of
D-type cyclin transcripts in quiescent human diploid fibro-
blasts (HDFs) stimulated with serum. We found that tran-
scription of the CCNDI and CCND3 genes is induced by
serum with kinetics characteristic of delayed early genes,
peaking at 12 hr after stimulation, prior to the onset of S
phase. Induction of CCND1 and CCND3 mRNAs correlates
with the state of the cell growth but is not sufficient for the
transition from quiescence through G1 into S phase.
MATERIALS AND METHODS
Cell Cultures and Reagents. HeLa, A-431, HepG2, WI-38,
and Hs68 cells were cultured in Dulbecco's modified Eagle's
medium (DMEM) containing 10%o (vol/vol) fetal calf serum.
H9 cells were cultured in RPMI 1640 medium supplemented
with 10%o fetal calf serum and 2 mM glutamine. Growth
factors were obtained from Upstate Biotechnology (Lake
Placid, NY). Phorbol 12-tetradecanoate (TPA) and cyclohex-
imide (CHX) were obtained from Sigma. Forskolin and
isobutylmethylxanthine (IBMX) were from Calbiochem.
Plasmid Constructions. pSPD1 was constructed by insert-
ing a Pst I-Pvu II fragment (-258 to +134) of the CCNDI
genomic clone G6 (10) into pSP65. pBSD3 carries an EcoRI-
Pst I fragment containing the first 182 base pairs (bp) of the
CCND3 cDNA clone H34 (10) inserted into pBS. The human
Abbreviations: HDF, human diploid fibroblast; CSF-1, colony-
stimulating factor 1; CHX, cycloheximide; TPA, phorbol 12-
tetradecanoate 13-acetate; IBMX, isobutylmethylxanthine; MPD,
mean population doublings; PDGF, platelet-derived growth factor;
EGF, epidermal growth factor; FGF, fibroblast growth factor.
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c-fos (FOS) antisense plasmid (kindly provided by M. Green-
berg) contains the BssHII-Xmn I fragment (-100 to +488) of
the FOS gene (13) inserted into pSP64. To produce template
for run-off transcripts, pSPD1 was linearized at the HindIII
site, and pBSD3 and FOS plasmids were linearized at the
EcoRI site of the vector polylinker sequence.
RNA Isolation and Analysis. Cytoplasmic RNA was pre-
pared from cells by the Nonidet P-40 method and treated with
DNase I (14). Uniformly labeled riboprobes for cyclin D1 and
FOS RNAs were prepared with SP6 RNA polymerase, and
the riboprobe for cyclin D3 was prepared with T3 RNA
polymerase (15). Equal amounts ofRNA were dissolved in 30
,uI of 40 mM Pipes, pH 6.7/0.4 M NaCl/1 mM EDTA
containing 5 X 105 cpm (Cerenkov) of each probe as indi-
cated, denatured at 850C for 5 min, and hybridized at 600C
overnight. A digestion mix (0.3 ml) of 10mM Tris, pH 7.5/0.3
M NaCl/5 mM EDTA/40 ,ug of RNase A per ml/2 ,g of
RNase T1 per ml was added and incubated at 16°C for 45 min.
Digestion was terminated by addition of 20 ,ul of 10% SDS and
5 ,ul of proteinase K at 10 mg/ml, followed by incubation at
37°C for 30 min. Samples were phenol/chloroform-extracted,
ethanol-precipitated, and electrophoresed on 8% polyacryl-
amide/8 M urea gels. Gels were visualized by autoradiogra-
phy and quantitated by exposing the dried gels to phosphor
screens and analyzing with a Molecular Dynamics Phosphor-
Imager equipped with ImageQuant software. Relative
changes in the levels of specific mRNAs were highly consis-
tent within the experimental series.
Metabolic Labeling and Cell Extract Analysis. Cells were
labeled for 3 hr with 45 ,uCi (1 ,uCi = 37 kBq) of [35S]me-
thionine (1129 Ci/mmol) per ml of methionine-free media.
Extracts from whole cells were prepared by several cycles of
freezing and thawing as described (16), and 20 ,ug of proteins
were separated on 0.1% SDS/10% polyacrylamide gels. The
gel was either stained with Coomassie blue or processed for
fluorography.
Flow Cytometric Analysis. Cells (106) were resuspended in
0.5 ml of phosphate-buffered saline containing 1% fetal calf
serum and 1 mM EDTA, fixed by gradual addition of ice-cold
80% ethanol while mixing, and stored for 1 hr at 4°C. The
fixed cells were resuspended in the same buffer and stained
for 30 min at 37°C with propidium iodide (Sigma) at 50 ug/ml
in the presence of RNase A at 0.1 mg/ml. The fluorescence
intensities ofthe samples were measured by quantitative flow
cytometry with an Epics C system (Coulter).
Analysis of DNA Synthesis. Cells were labeled with 3 ,uCi of
[3H]thymidine (34 Ci/mmol) per ml of media for 24 hr, rinsed
in phosphate-buffered saline, and then pelleted. Cell pellets
were resuspended in 0.25 ml of 0.3 M NaOH and incubated
on ice for 15 min. An equal volume of 209% trichloroacetic
acid was added, and incubation was continued on ice for 15
min. The extracts were then passed through Whatman GF/A
glass fiber filters and washed with ice-cold 10%o trichloroace-
tic acid followed by ice-cold 90% ethanol. Filters were dried
and quantitated by liquid-scintillation counting.
RESULTS
Genes Encoding Cyclins D1 and D3 Are Differentially Ex-
pressed in Transformed and Primary Human Cells. As a first
step to study the expression of D-type cyclins, various cell
types were surveyed to determine whether the cyclin genes
are expressed ubiquitously or in a restricted pattern. Cyto-
plasmic RNA isolated from growing cells was examined by
RNase protection analysis with probes specific for each of
the cyclin mRNAs. Although there were differences in the
levels of expression, cyclin D1 RNA was expressed in most
cells tested, with the exception of T-cell lines (Fig. 1, lane 4).
In contrast, cyclin D3 was expressed in all cells examined
(Fig. 1 and data not shown). Although this exposure does not
-
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FIG. 1. Relative abundance of cyclin D1 and D3 mRNAs from
transformed (epitheloid carcinoma HeLa, epidermoid carcinoma
A-431, hepatocellular carcinoma HepG2, T-cell lymphoma H9) and
primary (fibroblast WI-38 and Hs68) human cells. cDNA probes
specific for D1 and D3 mRNA were hybridized to 10 1Lg of cyto-
plasmic RNA and subjected to RNase protection analysis. The probe
fragments protected by D1 and D3 mRNA are indicated on the left.
show D3 RNA in HepG2 cells (Fig. 1, lane 3), it was
detectable on a longer exposure of the gel. In contrast to the
widely distributed pattern of expression for cyclins D1 and
D3, cyclin D2 expression was highly restricted. It was
detectable in two embryonal carcinomas (Tera-1 and Tera-2)
and in the T-cell line H9, barely detectable in HDFs, and
undetectable in a variety of other cell lines (unpublished
work). In addition, the levels of D1, D2, and D3 mRNAs
varied relative to each other among the different cell types.
Therefore, D-type cyclin genes are differentially expressed.
Kinetics of Induction of D1 and D3 Gene Expression by
Serum in HDFs. To determine if the abundance of cyclin
mRNAs changes upon reentry of quiescent cells into the cell
cycle, primary fibroblast Hs68 cells were made quiescent by
a 48-hr serum starvation and then were restimulated with 10%
serum. RNA was prepared from the cells at various times
after serum stimulation and analyzed by RNase protection
analysis with probes for D1, D3, and FOS mRNAs (Fig. 2
Upper). The FOS mRNA peaked at 30 min after stimulation
and was undetectable by 4 hr. In contrast, the levels ofD1 and
D3 cyclin mRNAs increased gradually, peaking at about 12 hr
after stimulation, and then declined slowly over the next 26
hr. Similar studies conducted in WI-38 cells gave identical
results (data not shown). Nuclear run-on assays showed that
the transcription rate of D1 and D3 cyclin genes increased in
response to serum, but not enough to account for the increase
in the steady-state mRNA levels (data not shown). Therefore,
posttranscriptional regulation may also contribute to the
increase in the levels of D1 and D3 mRNAs.
To determine whether induction of cyclin gene expression
coincided with cell-cycle progression, flow cytometric anal-
ysis was performed on the serum-stimulated cells (Fig. 2
Lower). Ninety-two percent of the serum-starved cells were
in G1 phase as estimated by DNA content. When the cells
were stimulated with 10% serum, the population of cells in S
phase peaked 20 hr after stimulation. Labeling with [3H]thy-
midine for 1-hr intervals confirmed the peak time point of S
phase to be 20 hr after stimulation (data not shown). Thus, the
levels of D1 and D3 cyclin mRNAs peak prior to the onset of
DNA synthesis.
The delay in induction of cyclin genes relative to FOS
raised the possibility that the activation of D1 and D3 gene
expression might require de novo protein synthesis. To test
this possibility, RNA levels were measured in cells stimu-
lated with serum in the presence of CHX (Fig. 3). The
induction of D1 and D3 cyclin mRNAs by serum was inhib-
ited by -60% by CHX. Another protein synthesis inhibitor,
puromycin, gave a similar result (data not shown). Consid-
ering that the induction of other secondary-response genes is
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4 0 4 Coomassie blue staining of the gel confirmed that the same
amount of protein was loaded in each lane, and fluorography
of the gel showed that protein synthesis was undetectable in
CHX-treated cells (data not shown). Thus, cyclin D gene
induction might occur through two pathways, one that re-
2 44 2 4 2 quires protein synthesis and another that does not. However,
2 2 3 the formal possibility exists that a very low level of protein
synthesis occurs that could not be detected by 35S-labeling
but that was sufficient to stimulate cyclin gene expression
19 0 slightly. Nevertheless, the full induction of D1 and D3 cyclin
genes by serum requires synthesis of new proteins, suggest-
ing that immediate early gene products might be required for
the expression of cyclin genes.
Induction of D1 and D3 Cyclin Gene Expression Correlates
1 4 7 with the State of Celi Growth. Since D-type cyclins may have
a role in growth control, we hypothesized that the level of
expression ofD1 and D3 cyclin genes might reflect the extent
M of cell proliferation. We examined this prediction using two
different approaches. First, cells were plated at subconfluent
levels and allowed to grow until arrested by contact inhibition
(Fig. 4A). The levels of D1 and D3 mRNAs were high in
exponentially growing cells and declined sharply as cells
approached confluence. In a second experiment, serum was
withdrawn from exponentially growing cells, and RNA was
prepared at various times (Fig. 4B). The levels of D1 and D3
mRNAs declined by 70% after 7 hr of serum deprivation.
Thus, HDFs respond to growth inhibitory signals such as cell
contact or the absence of growth factors by decreasing the
expression of the cyclin D genes. That proliferating cells
showed higher levels ofD1 and D3 mRNAs is consistent with
a role for D-type cyclins in growth control.
Differential Induction of D1 and D3 Cyclin Gene Expression
4 3 9 by Serum in Young and Old HDFs. With time in culture,
HDFs undergo profound molecular and physiologic changes
and finally lose the ability to respond to growth-stimulatory
d D3 cyclin gene signals (20). Because senescent HDFs have competent
rum after serum growth factor receptors (21), the block to proliferation must
icated, 5 gg of lie between the stimulation of membrane receptors and the
tNase protection initiation of S phase. Therefore, to determine if a decline of
mand cyclin D3 D-type cyclin gene expression correlates with this block to
rn starvation; M,
des). (Lower) At proliferation, we examined D1 and D3 mRNA levels in old
Harvested for flow cells stimulated with serum. When young [mean population
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d. fibroblasts were refed with serum, FOS mRNA rose to much
higher levels in young compared with old fibroblasts (Fig. 5,
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FIG. 3. Effect ofCHX on the induction of cyclin D1 and D3 gene
expression by serum. After serum starvation for 48 hr, Hs68 cells
were treated for 12 hr with 10% serum alone or in the presence of
CHX (35 gg/ml) or with CHX alone. Cytoplasmic RNA (5 Mug) was
analyzed for D1 and D3 transcripts by RNase protection.
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FIG. 4. The expression of D1 and D3 cyclin genes in growth-
arrested human diploid fibroblasts by contact inhibition and serum
starvation. (A) Hs68 cells were plated in DMEM containing 10%
serum in 10-cm culture dishes at 2 x 105 cells per dish. Cytoplasmic
RNA was prepared 2, 6, and 12 days after seeding as shown at the
top of lanes. Two days before each RNA preparation, cells were
given fresh medium. Equal amounts (5 ,g) ofRNA were analyzed by
RNase protection assay. (B) Hs68 cells in asynchronous growth (lane
1) were fed serum-free medium, and cytoplasmic RNA was prepared
at the indicated hours after serum withdrawal shown at the top of
lanes. Equal amounts (5 ,g) of RNA were analyzed by RNase
protection assay.
.
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FIG. 5. Differential induction of D1 and D3 cyclin gene expres-
sion in young and old fibroblasts. Young (MPD 30) and old (MPD 76)
fibroblasts were treated with 10o serum for 30 min or 12 hr after
serum starvation for 48 hr. Cytoplasmic RNA (5 ,ug) was analyzed by
RNase protection assay with cDNA probes for FOS, cyclin D1, and
cyclin D3 mRNAs. The same gel was exposed for 3 hr (D1) and 12
hr (D3 and FOS).
(22, 23). Similarly, young cells expressed higher levels of D1
and D3 cyclin mRNAs than did old fibroblasts in response to
serum (Fig. 5, lanes 3 and 6). Thus, the decline in the ability
of aging HDFs to proliferate in response to normally mito-
genic extracellular stimuli correlates with a decline in the
induction of cyclin gene expression.
Expression of D1 and D3 Genes Is Not Sufficient for the
Transition from Quiescence Through G, into S Phase. The
observation that the D1 and D3 cyclin genes are induced by
serum (Fig. 2) raises questions concerning the identity of the
inducer within the serum and the intracellular mediators of
the si
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were measured (Fig. 6). Treatment with 10% serum resulted
in an increase in D1 and D3 mRNA levels and [3H]thymidine
incorporation, as seen previously. In contrast, upon treat-
ment with IBMX, an inhibitor of cyclic nucleotide phospho-
diesterases, and forskolin, an activator of adenylate cyclase,
both the cyclin mRNA levels and [3H]thymidine incorpo-
ration declined, suggesting that activation of the cAMP
pathway leads to down-regulation of cyclin gene expression
and to growth arrest. Treatment with the BB form of PDGF,
EGF, or FGF resulted in an increase in D1 and D3 mRNA
levels as large as that produced by treatment with serum (Fig.
6A). Similarly, treatment with the phorbol ester TPA in-
creased cyclin mRNA levels, suggesting that activation of the
protein kinase C pathway can cause the induction of cyclin
genes. However, whereas treatment with the BB form of
PDGF induced DNA synthesis to the same extent as serum,
treatment with EGF or FGF produced only a moderate
increase, and treatment with TPA produced no change in
thymidine incorporation as compared with the control (Fig.
6B). Treatment with insulin-like growth factor 1 showed no
change in both cyclin mRNA levels and thymidine incorpo-
ration. Treatment with the AA form of PDGF, transforming
growth factor f3, or insulin failed to induce cyclin mRNAs but
resulted in small increases in thymidine incorporation. The
observation that treatment with TPA induces cyclin gene
expression with no effect on DNA synthesis suggests that
induction of D cyclin genes is not sufficient for entry into S
phase.
DISCUSSION
gnal. To identify specific growth factors able to induce Control of the commitment to DNA synthesis in mammalian
i gene expression, quiescent cells were treated with cells is likely to be more complex than in yeast (24, 25). In
us agents, and cyclin mRNA levels and DNA synthesis human cells, in addition to D-type cyclins (4, 8, 10, 12), at
least two other cyclins, C- and E-types (5, 6), have been
-E suggested to function as G1 cyclins. Although the function of
E PDGF each G1 cyclin and their interrelationships are not yet clear,
atment o* m ° PA it is likely that the function of the CLN-type cyclins in yeast
I TTPA- - l l- -- F | is fulfilled by multiple G1 cyclins in higher eukaryotes.
Moreover, the presence of multiple members within the same
D3
_ ^ ^ ^ ^ type of cyclin might reflect the more varied modes of prolif-
eration control in different cell types of higher eukaryotes.
oi1 __ _ Specifically, particular cyclins could be regulated by specific
extracellular signals in a cell-type-specific manner. Consis-
4.5 - tent with this model, we found that D-type cyclin genes are
differentially expressed among various cell types. Further-
4.0 - more, the cyclin D2 gene is differentially expressed in two
3.5 - different T-cell lines: it is highly expressed in H9 cells but
undetectable in Jurkat cells (unpublished work). Since H9
3.0- and Jurkat cells represent distinct stages of T-cell differen-
2.5
_ | tiation (26), the expression of D-type cyclin genes might be2.0- differentially regulated even within the same type of cells
E 2 . o - | | depending on the differentiation state. It is noteworthy that
CL 4 4 einHDFs where both D1 and D3 cyclin genes are expressed,
1.5 - nf* *growth factors induce these cyclins with the same kinetics
*.0- * n n n |(Fig. 6 and unpublished work), suggesting that common1.0-|| | | | | |signal transduction pathways and/or common regulatory
0. o - .mE elements are used to effect coordinate expression of these
:: I 1i11*i| | | | genes.
0.o-0 - ---- - -
-
Characteristic of a delayed early gene, the kinetics of[3H]Thymidine incorporation human cyclin D1 gene induction by serum in HDFs is
comparable to those of mouse D1 homolog by CSF-1 in
6. The induction of D1 and D3 cyclin gene expression by murine macrophages (7). However, there is a significant
ic growth factors. Hs68 cells were starved for 48 hr and treated amount of D1 mRNA present in serum-starved HDFs,
hr with 10% serum, IBMX and forskolin, TPA, the AA or BB whereasD*mRNA is undetectable in CSF-1-deprived mu-Of platelet-derived growth factor (PDGF), epidermal growth rim(EGF), fibroblast growth factor (FGF), transforming growth tine macrophages. Furthermore, althoughDi mRNA induc-/3 (TGF), insulin (INS), or insulin-like growth factor 1 (IGF). tion was only partially blocked by CHX in HDFs, Dl mRNA
ytoplasmic RNA (5 ,g) was analyzed by RNase protection induction was completely blocked in murine macrophages.
(B) [3H]Thymidine incorporation at 24 hr was measured as These differences could be explained simply by differences in
ibed in text. the sensitivities of the assays for cyclin expression or by
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differences in the cell types and growth factor treatments
used for the study of human and mouse D-type cyclins.
Murine macrophages are dependent only on CSF-1 for their
proliferation and survival (27). These cells die within 36 hr
when deprived of CSF-1. In contrast, Hs68 cells do not lose
their viability when grown in serum-free medium for several
days and retain the ability to reenter the cell cycle upon serum
stimulation (unpublished work). Therefore, D1 mRNA induc-
tion and degradation in murine macrophages may be more
tightly associated with the dependency ofthe cells on mitogens
than cyclin D1 mRNA in HDFs.
Our studies using HDFs show that expression of D-type
cycin genes correlates with the state of cell growth. This is
also supported by elutriation experiments with cycling HeLa
cells, which showed that D1 and D3 cyclin mRNA levels
cycle weakly with a peak during G1 (unpublished work).
Similar results were obtained with HeLa cells and fibroblasts
that were blocked by drug treatment and then released (ref.
8 and unpublished work). Consonant with the decrease in the
expression of D1 and D3 cyclins in HDFs under unfavorable
growth conditions (Fig. 4), the decrease in the induction of
cyclin gene expression by serum in aging HDFs (Fig. 5) may
be one of a series of events involved in the growth arrest
associated with senescence. In senescent cells there is re-
pression oftwo types of temporally separated growth-related
genes, FOS and cyclin genes (22, 23, 28) (Fig. 5). In contrast,
an increase in the level of cAMP induces FOS expression in
HDFs (23) but inhibits D1 and D3 cyclin gene expression
(Fig. 6), indicating that FOS and cyclin D gene expression are
not always linked. Like HDFs, CSF-1-dependent murine
macrophages are also arrested by cAMP analogs in the G1
phase ofthe cell cycle (29). Since cAMP does not block either
CSF-1-activated signaling pathways or several immediate
responses to CSF-1, including the induction of Fos and Myc
mRNA (29), cAMP-mediated growth arrest might occur later
in G1 (30). The effects of cAMP on the expression of cyclin
D genes in macrophages are unknown. Since these genes are
delayed early genes and may be involved in the G1 to S
transition, they might be specifically targeted for repression
by cAMP. Therefore, we suggest that in CSF-1-dependent
murine macrophages and HDFs, cAMP might act directly on
the cyclin D genes to repress their expression and that
down-regulation of G1 cyclins by cAMP might be an impor-
tant event contributing to the G1 block.
Our data suggest that induction of D-type cyclin gene
expression is not sufficient to induce DNA synthesis. It is
possible that D-type and other types ofcyclins function either
together or separately during G1 and at the G1 to S transition
and that cooperativity among different types of cyclins is
required for the onset of DNA synthesis. It is also possible
that the function ofD-type cyclins is at the point of entry into
the proliferative cycle, the Go/Gj boundary, and that other
cyclins are required to traverse the G1 phase and induceDNA
synthesis. These may be induced by signal transduction
pathways that are distinct from those that induce D-type
cyclin gene expression.
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